FP
IPXL

Foundry Partners’s Impax Laboratories, Inc. IPXL Stock Holding History

Foundry Partners’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,260
Closed -$296K – 384
2016
Q2 		$296K Buy
10,260
+2,330
+29% +$75.9K 0.02% 337
2016
Q1 		$254K Hold
7,930
– – 0.03% 249
2015
Q4 		$339K Buy
+7,930
New +$317K 0.03% 226
2015
Q2 		– Sell
-7,112
Closed -$333K – 290
2015
Q1 		$333K Sell
7,112
-3,558
-33% -$142K 0.03% 234
2014
Q4 		$338K Sell
10,670
-3,236
-23% -$94.7K 0.03% 216
2014
Q3 		$330K Sell
13,906
-250
-2% -$6.4K 0.03% 235
2014
Q2 		$425K Sell
14,156
-65
-0.5% -$1.75K 0.04% 225
2014
Q1 		$376K Buy
14,221
+1,046
+8% +$26.1K 0.04% 249
2013
Q4 		$331K Buy
+13,175
New +$294K 0.03% 262

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Foundry Partners's IPXL Position: Q3 2016 in Review

Foundry Partners sold out of Impax Laboratories, Inc. (IPXL) in Q3 2016, closing a stake of 10,260 shares — an estimated $296K sold.

Foundry Partners first reported a position in IPXL in Q4 2013 and held it in 9 quarters. The position peaked at $425K in Q2 2014. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

  • Foundry Partners reported no remaining Impax Laboratories, Inc. position as of Q3 2016 after selling out during the quarter.
  • Foundry Partners sold 10,260 Impax Laboratories, Inc. shares in Q3 2016, an estimated $296K.
  • Foundry Partners first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 9 quarters.
  • Foundry Partners's Impax Laboratories, Inc. position peaked at $425K in Q2 2014.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Foundry Partners's 13F filing for Q3 2016, filed 6 Oct 2016.